Mind The Gap #W19
European Tech & VC weekly signal over noise. News, deals, funds, & exits.
📅 May 04 – 10, 2026 | Read time: 5 mins
Quantum & Defense week. Four quantum computing rounds landed in the same seven days, which is either a coincidence or a signal that European deep tech investors have made their bets on where the next compute paradigm starts. Helsing moving toward an $18B valuation is the other number worth sitting with. Defence AI is no longer a niche category. It is becoming one of the most generously priced sectors in European private markets, and the institutional conviction behind it is accelerating.
📰 News of the Week
Helsing set for $18B valuation in new funding round
The German AI defence company is reportedly raising at approximately $18B, placing it among Europe’s most valuable private tech companies. The institutional repricing of AI-driven defence assets shows no sign of slowing.
ICEYE targets €250M raise at €2.4B+ valuation
The Finnish satellite imaging company is in talks to raise €250M according to Bloomberg, with defence contracts pushing its valuation above €2.4B. Another data point on how dual-use and space infrastructure are being repriced in 2026.
SAP acquires Prior Labs for €1B+ commitment
SAP signed a definitive agreement to acquire Freiburg-based Prior Labs, the pioneer of Tabular Foundation Models, and committed more than €1B over four years to scale it into a European frontier AI lab. Prior Labs retains its brand, team, and open-source commitments.
Doctolib acquires Medicus Health and commits £100M+ to the UK market
The French healthtech unicorn bought UK primary care software startup Medicus Health, pledging over £100M in investment and 150 new hires. It puts Doctolib in direct competition with the Optum and TPP duopoly that has long controlled UK primary care infrastructure.
🇪🇺 Top Deals of the Week
ElevenLabs | $550M+ | United Kingdom | AI | Series D | Sequoia Capital, a16z, ICONIQ, BlackRock
Quantum Motion | $160M | United Kingdom | Quantum | Series C | DCVC, Kembara, British Business Bank
QuantWare | €152M | Netherlands | Quantum | Series B | Intel Capital, In-Q-Tel, ETF Partners
LegalPlace | €70M | France | LegalTech | Move Capital, XAnge, Eurazeo
Nyobolt | $60M | United Kingdom | CleanTech | Series C at | $1B EV | Symbotic
eleQtron | €57M | Germany | Quantum | Series A | Schwarz Digits, EIC Fund, Earlybird
Smartness | €47M | Italy | TravelTech | Series B | United Ventures, CDP Venture Capital, Partech
Skeleton Technologies | €33M | Estonia | AI Infrastructure | Axon Partners, Taiwania Capital
SWEBAL | €30M | Sweden | Defence | BA
Qutwo | €25M | Finland | AI / Quantum | €325M EV | BA
Ethos | $22M | United Kingdom | HR Tech | a16z
Lithosquare | €21.3M | France | Critical Minerals | World Fund, Kindred Capital
EnteroBiotix | £19M | United Kingdom | BioTech| Thairm Bio, Scottish National Investment Bank
OpenTrade | $17M | United Kingdom | Crypto | Mercury Fund, Notion Capital
Reel | €15M | Denmark | EnergyTech | Future Energy Ventures
🚪 Exits
Medicus Health | Acquired by Doctolib | United Kingdom | HealthTech
Legalstart | Acquired by LegalPlace | France | LegalTech
Moonfish AI | Acquired by Batch | France | Marketing Tech
VeloLife | Acquired by Laka | United Kingdom | InsurTech / Micromobility
QHarbor | Acquired by Quantum Machines | Netherlands | Quantum Computing
Prior Labs | Acquired by SAP | €1B+ commitment | Germany | AI
Moove Connected Mobility | Acquired by Netradyne | Europe | Mobility
Getaround Europe | Merged with GoMore | Europe | Mobility
Sastrify | Acquired by Deel | Germany | Software Procurement
🔍 My Personal Favorite
Moonlight AI | HealthTech / AI Diagnostics | Seed | €2.8M
Moonlight AI targets a specific bottleneck in oncology: extracting genomic biomarker information from standard blood and cytology slides, a modality that is widespread and low-cost but conventionally unable to yield molecular-level insight without separate genetic assays. The approach applies AI image analysis to existing imaging workflows to infer genomic features, positioning it as a non-destructive overlay on current lab practice rather than a replacement modality. This matters technically because it reduces dependency on expensive next-generation sequencing or immunohistochemistry panels for initial biomarker screening, compressing both time-to-result and cost per patient. The syndicate includes MEDIN Fund and VP Venture Partners, investors with sector-specific diligence capacity. The visual-to-genomic inference layer in cancer diagnostics is structurally underserved, and the approach has defensible IP potential if training data and model architecture remain proprietary.
💸 New Dry Powder
Front Ventures | €5M | Ukraine | Defence Tech, Ukraine-focused
Araya Sie Fund | £7.5M (first close) | United Kingdom | Women-led startups, seed stage, up to 40 portfolio companies
Thank you for reading.
Don’t just read the market: understand it.
If you enjoyed this edition, share it with someone who should be tracking European VC.
See you next week for more Tech & VC insights.
Best,
Agathe